| Product NDC: | 0430-0115 |
| Proprietary Name: | DORYX |
| Non Proprietary Name: | doxycycline hyclate |
| Active Ingredient(s): | 150 mg/1 & nbsp; doxycycline hyclate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, DELAYED RELEASE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0430-0115 |
| Labeler Name: | Warner Chilcott (US), LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA050795 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20110921 |
| Package NDC: | 0430-0115-95 |
| Package Description: | 48 CARTON in 1 CASE (0430-0115-95) > 1 BOTTLE in 1 CARTON > 3 TABLET, DELAYED RELEASE in 1 BOTTLE |
| NDC Code | 0430-0115-95 |
| Proprietary Name | DORYX |
| Package Description | 48 CARTON in 1 CASE (0430-0115-95) > 1 BOTTLE in 1 CARTON > 3 TABLET, DELAYED RELEASE in 1 BOTTLE |
| Product NDC | 0430-0115 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | doxycycline hyclate |
| Dosage Form Name | TABLET, DELAYED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20110921 |
| Marketing Category Name | NDA |
| Labeler Name | Warner Chilcott (US), LLC |
| Substance Name | DOXYCYCLINE HYCLATE |
| Strength Number | 150 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |